(19)
(11) EP 4 816 389 A1

(12)

(43) Date of publication:
07.10.2026 Bulletin 2026/41

(21) Application number: 24840943.5

(22) Date of filing: 27.11.2024
(51) International Patent Classification (IPC): 
C07K 14/565(2006.01)
A61K 48/00(2006.01)
C07K 7/06(2006.01)
A61K 38/17(2006.01)
A61P 27/02(2006.01)
C07K 14/81(2006.01)
(52) Cooperative Patent Classification (CPC):
A61P 27/02; C07K 14/565; C07K 14/811; C07K 7/06; C12N 15/85; A61K 38/00
(86) International application number:
PCT/US2024/057784
(87) International publication number:
WO 2025/117767 (05.06.2025 Gazette 2025/23)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA
Designated Validation States:
GE KH MA MD TN

(30) Priority: 29.11.2023 US 202363604026 P

(71) Applicant: The United States of America, as represented by the Secretary, Department of Health and Human Services
Bethesda, Maryland 20892-7788 (US)

(72) Inventors:
  • BECERRA, Sofia Patricia
    Bethesda, Maryland 20892 (US)
  • BERNARDO-COLON, Alexandra
    Bethesda, Maryland 20892 (US)
  • SWENSON, Rolf E.
    Rockville, Maryland 20850 (US)
  • BLACKMAN, Burchelle N.
    Bethesda, Maryland 20814 (US)
  • DEBNATH, Subrata
    Bethesda, Maryland 20892 (US)
  • RAJU, Natarajan
    Rockville, Maryland 20850 (US)

(74) Representative: Mewburn Ellis LLP 
Aurora Building Counterslip
Bristol BS1 6BX
Bristol BS1 6BX (GB)

   


(54) MODIFIED PIGMENT EPITHELIUM-DERIVED FACTOR PEPTIDES AND METHODS OF USE